Jbs N.V. · JBS · FY2026 Q2 · Calendar Q3 2026

JBS: Q2 EBITDA resilient as beef margins improve and expansion accelerates

JBS's Q2 supports a constructive operating thesis: EBITDA remained resilient, free cash flow improved and management identified margin and geographic expansion drivers. The counterweight is rising capex, 3.1x net leverage and uncertainty around beef supply and pork demand.

Reported After market closeNYSEConsumer Defensive $26.53B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.20 Consensus $0.31
EPS surprise -35.0% Reported versus consensus
Reported revenue $23.90B Consensus $23.04B
Revenue surprise +3.7% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -2.9% Event window
SPY move -0.3% Same window
Abnormal move -2.6% Stock minus SPY
Volume 2.4× Versus trailing sessions
Subsequent drift -3.4% Up to 20 sessions
JBSSPY benchmark

Ask FN2 about JBS FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior quarter, JBS moved from negative free cash flow to positive $130 million, while adjusted EBITDA reached $1.43 billion and the margin improved to 6%. The company also added a $2.5 billion equity investment for a 25% Australia/New Zealand stake, creating funding capacity for Southeast Asian expansion.

Guidance delta

Maintained; management targeted 2026 cash-flow breakeven EBITDA of $5.1 billion.

Key takeaways

  • Adjusted EBITDA was $1.43 billion, a 6% margin, despite volatile markets.
  • Free cash flow turned positive at $130 million while capex rose to $163 million.
  • The Australia/New Zealand joint venture adds growth funding for Indonesia and Southeast Asia.
  • Pork margins remained strong, but management flagged weaker pork demand.

Management priorities

  • Expand value-added beef offerings and integrate the Australia/New Zealand joint venture.
  • Invest in Indonesia and broader Southeast Asia.
  • Continue disciplined capital allocation, cash generation and leverage reduction.
  • Increase retail and direct-to-consumer protein channels.

Follow JBS with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
JBS EPS earnings history estimate and actual scatter chart 5 reported fiscal quarters and 4 future estimate-only quarters. Q2 '25 estimate $0.51 Q2 '25 actual $0.53, beat Q3 '25 estimate $0.51 Q3 '25 actual $0.52, beat Q4 '25 estimate $2.26 Q4 '25 actual $0.39, miss Q1 '26 estimate $0.20 Q1 '26 actual $0.20, match Q2 '26 estimate $0.31 Q2 '26 actual $0.20, miss Q3 '26 estimate $1.62 Q4 '26 estimate $1.56 Q1 '27 estimate $0.74 Q2 '27 estimate $1.58

Analyst Consensus ?

ConsensusBuy4 ratings
Bullish4100.0%
Neutral00.0%
Bearish00.0%

Analyst 52W Price Targets

$12.03Current
$17Low
$18.33Average
$20High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Buy BuyMaintainAug 24, 2026
Stephens & Co. Overweight OverweightMaintainAug 17, 2026
JP Morgan Overweight OverweightMaintainAug 12, 2026
Barclays Overweight OverweightMaintainJul 16, 2026

Named analyst price targets

Upside is calculated against the persisted current price $12.03. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSAnalyst unavailable$17.5$13.82 +45.5%Aug 24, 2026
StephensPoorah Sharma$17$13.65 +41.3%Aug 17, 2026
BarclaysAnalyst unavailable$20$12.1 +66.3%Jul 16, 2026
UBSAnalyst unavailable$17$12.52 +41.3%May 19, 2026
BarclaysAnalyst unavailable$23$17.03 +91.2%Mar 27, 2026
UBSAnalyst unavailable$19.5$15.73 +62.1%Feb 5, 2026
Banco SantanderGuilherme Palhares$17$14.03 +41.3%Dec 11, 2025
Goldman SachsAnalyst unavailable$18.5$14.53 +53.8%Nov 26, 2025
Mizuho SecuritiesAnalyst unavailable$20$13.16 +66.3%Oct 28, 2025
Show less

Track every rating change on JBS the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

JBS NV is a food company that engages in the sale of beef, pork, lamb meat and poultry products. It offers its products to supermarkets, club stores, other retail distributors, and foodservice companies. The company was founded on October 9, 2019 and is headquartered in Amstelveen, the Netherlands.

Consumer Defensive peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the JBS recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-11T20:11:54.753008+00:00
  2. FN2 earnings calendar · 2026-09-15T01:23:15.305287+00:00
  3. Polygon adjusted daily market bars · 2026-09-21T18:30:52.128034+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T18:30:52.125122+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.